NCT04343404

Brief Summary

Describe COVID-19 patients who are receiving ECMO-VV respiratory replacement and what happens to them.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2020

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

April 8, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 13, 2020

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2020

Completed
Last Updated

June 29, 2020

Status Verified

April 1, 2020

Enrollment Period

14 days

First QC Date

April 8, 2020

Last Update Submit

June 25, 2020

Conditions

Respiratory Distress Syndrome

Keywords

Respiratory Distress SyndromeARDSSARS-COV-2Extracorporeal membrane oxygenationECMOVeno-venous ECMO

Outcome Measures

Primary Outcomes (1)

  • Retrospective description of COVID-19 patients receiving respiratory ECMO-VV supplementation and what happens to them

    Files analysed retrospectily from March 1st, 2020 to April 15, 2020 will be examined

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients with a COVID-19 diagnosis by RT-PCR

You may qualify if:

  • Patient over the age of 18;
  • Diagnostic COVID-19 by RT-PCR;
  • Hospitalisation in resuscitation for the management of complications related to COVID-19
  • Implanted ECMO-VV during hospitalisation;
  • Patient agreeing to participate in the study

You may not qualify if:

  • Sujet under guardianship or trusteeship
  • Sujet under safeguard of justice

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

Location

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Pierre-Emmanuel FALCOZ, MD, PhD

    Service de Chirurgie Thoracique Nouvel Hôpital Civl Hôpitaux Univesitaires de Strasbourg

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2020

First Posted

April 13, 2020

Study Start

April 1, 2020

Primary Completion

April 15, 2020

Study Completion

April 15, 2020

Last Updated

June 29, 2020

Record last verified: 2020-04

Locations

FR(1)